Medicine & Life Sciences
Nicotinic Receptors
100%
Positron-Emission Tomography
51%
2-(6-fluoro-2,3'-bipyridin-5'-yl)-7-methyl-7-azabicyclo(2.2.1)heptane
49%
7-azabicyclo(2.2.1)heptane
47%
3-(1,4-diazabicyclo(3.2.2)nonan-4-yl)-6-fluorodibenzo(b,d)thiophene 5,5-dioxide
44%
Brain
34%
Papio
33%
Ligands
19%
Kinetics
17%
2-(6-methyl-3,6-diazabicyclo(3.2.0)heptan-3-yl)-7-(6-methyl-3,6-diazabicyclo(3.2.0)heptan-3-yl)-9H-fluoren-9-one
16%
Radioactivity
16%
Cannabinoid Receptors
16%
5-(6-(5-methylhexahydropyrrolo(3,4-c)pyrrol-2(1H)-yl)pyridazin-3-yl)-1H-indole
16%
Cannabinoids
15%
AT-1001
13%
lactosides
12%
dibenzothiophene
11%
Cannabinoid Receptor CB2
11%
Mannosides
10%
Heptanes
10%
Carbon-11
10%
Ethers
10%
Plant Lectins
9%
pyrazole
9%
Neuropsychiatry
9%
Thalamus
9%
indole
8%
Cannabinoid Receptor CB1
8%
Cholinergic Receptors
7%
4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
7%
Lactose
7%
Microwaves
7%
Radiochemistry
7%
cyclopropanecarboxamide
7%
Neuroimaging
7%
Amyloidosis
7%
Cholinergic Antagonists
7%
Blood-Brain Barrier
6%
Carbohydrates
5%
N-acetyllactosamine
5%
Cycloaddition Reaction
5%
Chemical Compounds
Radioligand
60%
Acetylcholine
55%
Positron
37%
Heptane
27%
Kd
19%
Cannabinoid
16%
L-Arginine Derivative
13%
Radioactivity
12%
Ligand
12%
Lipopolysaccharide
10%
Compound Z
10%
Anilide
8%
L-Arginine
8%
Antagonist
8%
Silsesquioxane
7%
Radiochemical Yield
7%
Dibenzothiophene
7%
Agent Interacting With Transmitter, Hormone or Drug Receptor
7%
Lactose
7%
2,2,3,3-tetramethylcyclopropanecarboxylic Acid
6%
Amide
6%
Reaction Step
6%
Enantiomer
6%
Reaction Yield
6%
Molecular Recognition
6%
Quality Control
5%
Label
5%
Total Synthesis
5%
Cannabinoid 2 Receptor Agonist
5%
Pharmacological Metabolism
5%
